Sugarloaf Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.61K | Hold |
4
| – | – | ﹤0.01% | 636 |
|
|
2024
Q3 | $1.86K | Hold |
4
| – | – | ﹤0.01% | 622 |
|
|
2024
Q2 | $1.88K | Hold |
4
| – | – | ﹤0.01% | 591 |
|
|
2024
Q1 | $1.67K | Hold |
4
| – | – | ﹤0.01% | 600 |
|
|
2023
Q4 | $1.63K | Hold |
4
| – | – | ﹤0.01% | 612 |
|
|
2023
Q3 | $1.39K | Hold |
4
| – | – | ﹤0.01% | 617 |
|
|
2023
Q2 | $1.41K | Hold |
4
| – | – | ﹤0.01% | 632 |
|
|
2023
Q1 | $1.26K | Sell |
4
-12
| -75% | -$3.78K | ﹤0.01% | 635 |
|
|
2022
Q4 | $4.62K | Buy |
16
+12
| +300% | +$3.47K | ﹤0.01% | 589 |
|
|
2022
Q3 | $2K | Hold |
4
| – | – | ﹤0.01% | 720 |
|
|
2022
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 753 |
|
|
2022
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 697 |
|
|
2021
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 727 |
|
|
2021
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 736 |
|
|
2021
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 725 |
|
|
2021
Q1 | $1 | Hold |
4
| – | – | ﹤0.01% | 724 |
|
|
2020
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 694 |
|
|
2020
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 652 |
|
|
2020
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 654 |
|
|
2020
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 664 |
|
|
2019
Q4 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 681 |
|